Found 412 hits.
| 170 | Weller, K., Groffik, A., Magerl, M., Tohme, N., Martus, P., Krause, K., Metz, M., Staubach, P., and Maurer, M.+: Development, validation, and initial results of the angioedema activity score. Allergy 2013: 68; 1185-1192. IF: 5.99 |
|
495. |
Brzoza, Z.+, Badura-Brzoza, K., Maurer, M., Hawro, T., and Weller, K.: Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria – results from the validation of the Polish urticaria control test. World Allergy Organ J. 2022: 15; 100635. IF: 5.10 |
o.495
| 336 | Kocatürk, E.+, Kiziltac, U., Can, P., Öztas Kara, R., Erdem, T., Kiziltac, K., Sahillioglu, N., Gelincik, A., Maurer, M., and Weller, K.: Validation of the Turkish version of the urticaria control test: correlation with other tools and comparison between spontaneous and inducible chronic urticaria. World Allergy Organ. J. 2019: 12; 6-13. IF: TBD (IF 2018: 3.68) |
o.336
| 124. | Sánchez-Borges, M., Caballero-Fonseca, F., Capriles-Hulett, A., González-Aveledo, L., and Maurer, M.: Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria. J. Eur. Acad. Dermatol. Venereol. 2017: 31; 964-971. IF: 4.29 |
r.124
| 360 | Maurer, M.+, Giménez-Arnau, A. M., Sussman, G., Metz, M., Baker, D. R., Bauer, A., Bernstein, J. A., Brehler, R., Chu, C.-Y., Chung, W.-H., Danilycheva, I., Grattan, C., Hebert, J., Katelaris, C., Makris, M., Meshkova, R., Savic, S., Sinclair, R., Sitz, K., Staubach, P., Wedi, B., Löffler, J., Barve, A., Kobayashi, K., Hua, E., Severin, T., and Janocha, R.: Ligelizumab for chronic spontaneous urticaria. New Engl. J. Med. 2019: 381; 1321-1332. IF: 74.70 |
o.360
| 382. | Bertolin-Collilla, M., Garin-Boronat, O., Siebenhaar, F., Maurer, M., Pujol, R. M., and Giménez-Arnau, A. M.+: Translation and cultural adaption of the German mastocytosis quality of life questionnaire (MC-QoL) into Spanish. Actas Dermosifilogr. 2020: 111; 243-248. IF: N/A |
o.382
| 410. | Chen, Y., Yu, M., Huang, X., Tu, P., Shi, P., Maurer, M.+*, and Zhao, Z.+*: Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both. World Allergy Organ. J. 2021: 14; 100501. IF: 5.52 |
o.410
| 302 | Caballero, T.+, Zanichelli, A., Aberer, W., Maurer, M. Longhurst, H. J., Bouillet, L., and Andresen, I.: Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the icatibant outcome survey, a cohort observational study. Clin. Transl. Allergy 2018: 8; 11. IF: 4.23 |
| 59 | Magerl, M., Lammel, V., Siebenhaar, F., Zuberbier, T., Metz, M., and Maurer, M.+: Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells. Exp. Dermatol. 2008: 17; 427-435. IF: 3.26 |
o.059
| 106. | Schmetzer, O., Valentin, P., Church, M. K., Maurer, M., and Siebenhaar, F.: Murine and human mast cell progenitors. Eur. J. Pharmacol. 2016: 778; 2-10. IF: 2.89 |
r.106